BioSig Technologies Reinvests in Lafayette College’s InternShift Progam
Santa Monica, CA, Nov. 20, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical […]
Nemaura Signs License and Distribution Agreement for SugarBEAT® Commercial Launch in Qatar
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose […]
Evine Appoints Jon Sanders as Senior Vice President General Manager of Fulfillment and 3rd Party Logistics
MINNEAPOLIS, Nov. 20, 2018 (GLOBE NEWSWIRE) — Evine Live Inc. (“Evine”) (NASDAQ:EVLV), a multiplatform interactive video and digital commerce company (evine.com), recently […]
Enphase Energy Storage Installations Reach Over 12,500 Homes
FREMONT, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world’s […]
Aeglea BioTherapeutics to Present at Evercore ISI HealthconX Conference
Company to Webcast Fireside Chat on Tuesday, November 27 at 2:45 p.m. ET AUSTIN, Texas, Nov. 20, 2018 (GLOBE NEWSWIRE) […]
Krystal Biotech to Present at Evercore ISI HealthCONx
PITTSBURGH, Nov. 20, 2018 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing […]
InformationWeek Names Talend Among “Top Vendors to Watch in 2019”
Talend cited on “Who’s Hot in Data & Analytics” list REDWOOD CITY, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) — Talend […]
Immune Design to Present at Piper Jaffray 30th Annual Healthcare Conference
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) — Immune Design (Nasdaq: IMDZ), an immunotherapy company focused […]
CymaBay Therapeutics to Participate in Upcoming Investor Conferences
NEWARK, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing […]
Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia
IRVINE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical […]
